In fact, HO-1 can confer cytoprotective, anti-apoptotic, and anti-inflammatory properties, thus becoming a possible pharmacological approach for the management of various gastrointestinal diseases, namely IBD [16,25]. The gene discussed is HMOX1; the disease is inflammatory bowel disease.